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THIS and the following two papers will describe attempts to determine the
chemical basis of the malignancy of certain cancer cells by methods employed
in identifying the virulence attributes of pathogenic micro-organisms (Smith,
1964). " Malignancy " has been defined similarly to " virulence " in micro-
biology, namely, the ability of cancer cells to invade and kill a host.
Common features in malignancy and microbial infection have been suggested
(Sanford, Merwin, Hobbs and Earle, 1959; Foley and Drolet, 1964). Thus
malignancy, like virulence, appears to vary and to depend on genetic and environ-
mental factors. Cancer "strains" of differing malignancy exist (Shelton and
Rice, 1958) and malignancy can be increased by animal passage and decreased bv
culture in vitro. Additional features common to cancer and infectious disease are
the importance of host defence mechanisms (serum, the reticuloendothelial
system, etc.) in resisting tumour invasion (Southam, 1960; Mihich, 1962; Klein,
1966), the tendency for cancer cells to grow better in some tissues than others
(Moore, 1961) and the production of active immunity by inoculating malignant
cells (Goldin and Humphreys, 1960).
However, cancer cells are more similar to host cells than are invading micro-
organisms. The differences between cancer cells and normal cells which are
responsible for malignancy are probably more subtle than those determining
virulence in pathogenic micro-organisms. Nevertheless, the analogy suggests an
approach to the investigation of malignancy based on microbial methods. For
example, aspects that might be investigated include the possible existence of
materials called aggressins in microbiology-which interfere with host defence
mechanisms; and the possibility of toxin production, particularly by tumours
which kill when a relatively small amount of tumour growth has occurred.
One approach to studies of bacterial virulence seemed particularly applicable
to cancer. Strains of differing virulence, produced from one bacterial species,
have been used to investigate the factors responsible for the difference in virulence;
(a) byr comparing their biological and chemical behaviour, particularly in vivo
and (b) by endeavouring to increase the virulence of the less virulent strain by
adding products of the more virulent strain (Smith, 1958).
The aim was first to prepare from an artificially induced or spontaneous
tumour, cell lines of differing malignancy and then to compare them by quantita-
tive biological tests similar to those used in microbiology. To carry out the
latter, ascites tumours were desirable or solid tumours which could be easily
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reduced to single cell suspensions. This paper describes the production of such
cell lines from a carcinogen induced tumour in rats and a spontaneous lymphoma
in mice.
Tumour systems for comparative studies obtained by the attenuation of
malignancy by culture in vitro (Dawe, Potter and Leighton, 1958; Cailleau and
Costa, 1961; Cailleau and St. Armand, 1963; Takahashi, 1963) are open to objec-
tion. The differences observed may be due to major alterations in the trans-
plantation characteristics ofthe cells in vitrorather than to changes in malignancy.
An alternative method which avoids this objection and parallels studies on
pathogenic micro-organisms grown in vivo (Smith, 1964) is to use tumour pro-
gression. Passage of a tumour in isogeneic animals increases its malignancy
(MacDowell, 1946; Foulds, 1954; Sato, Belkin and Essner, 1956; Mori, Harada
and Yamaoka, 1963; Maruyama and Knuth, 1966; Steel, Adams and Barrett,
1966). By freezing cells at the beginning and the end of the progression, closely
related sub-lines of differing malignancy have been obtained.
In investigating malignancy in this manner we agree with Paul (1966) over the
difficulties inherent in comparative studies with normal and cancer cells. Fre-
quently, the normal cell from which the tumour arose cannot be determined and
eventhen the normal cell may be static whereasthetumour cellis activelydividing.
" Minimal deviation tumours " (Potter, 1964) and tissue culture lines, transformed
spontaneously or by virus, did not offer the parallelism with the microbial model
as did the system involving tumour progression.
MATERIALS AND METHODS
Animats
Rats: The inbred black and white hooded (Chester Beatty Research Institute)
strain.
Mice: The inbred AKR strain.
These animals were bred under specific pathogen free (SPF) conditions. The
animals were isogeneic as indicated by periodic skin grafting tests between
different animals of the populations.
Induction of tumours in rats, conversion to the ascitesform and s8ubsequent passage
Tumours were induced subcutaneously by pellets of 3,4-benzopyrene or
20-methylcholanthrene. Seven to eleven months later, the solid tumours (1-2 cm.
diameter) were removed and cell suspensions prepared with a stainless steel sieve
and TGC (Tyrode solution containing gelatin (0.2 %) and sodium citrate (0.25%O))
solution as diluent. The cell suspensions (ca. 1 x 108 cells) were injected intra-
peritoneally into rats. Subsequent intraperitoneal passage of the tumours was
done with cell suspensions obtained by washing out the peritoneal cavitv with
TGC solution. Viable tumour cells from selected passage generations were
preserved by freezing for subsequent determination of their degree of malignancy
(see below).
Conversion of mouse lymphomas to the ascitesform and their subsequent passage
Cell suspensions prepared as above from the thymus glands, mesenteric
lymph nodes or spleens of AKR mice (6-12 months) having spontaneous lympho-
mas, were injected intraperitoneally into AKR mice. Subsequent passage was
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carried out as described for the rat tumours. Sieved solid tumours were used
where ascitic growth had not occurred.
Cells from several passages were preserved by freezing for subsequent deter-
mination of their degree of malignancy.
Total tumour cell counts
These were done in a haemocytometer.
Estimation of tumour cell viability
Cells suspended in TGC solution containing eosin (0.2 %) were examined within
5 minutes for the proportion ofviable (unstained) cells.
Preservation of tumour cells byfreezing
Cells were suspended either in a mixture of dimethylsulphoxide (5 %) in calf
serum (for rat tumours) or glycerol (5 %) in calf serum (for mouse tumours).
Samples (1 ml.) in screw-capped vials were cooled to - 70° at ca. 1°/min, and were
then transferred to a liquid nitrogen bank. Samples were thawed rapidly and
resuspended in TGC solution for injection intraperitoneally into the appropriate
animals.
Assessment of the degree of malignancy of tumours by mean death time estimation
Groups (10-20) ofrandomized weighed animals were injected intraperitoneally
with a measured dose of tumour cells which contained less than 10% of normal
cells. Animals were observed daily until 30 days after the last recorded death
(in the case oflow doses) or until all animals in the group had died. Mean death
times for each group were calculated.
RESULTS
Tumours in rats
Derivation of two sub-lines of a tumour with differing malignancy.-A tumour
(WBP1) growing as a blood-free suspension of cells in the peritoneal cavity was
established after the third passage of a benzopyrene induced solid tumour and
several passage generations ofit were frozen down. It soon became apparent that
tumour progression was occurring as, during the serial passage of approximately
1 X 108 cells, the average survival time of the rats decreased.
Two passage generations-the 7th and 21st-were chosen because they had a
large difference in malignancy and adequate stocks of cells could be frozen from
the early and late passage generations. A " double stock " system was instituted.
Cells of the " working stock " were from the previous passage generation twice
removed from the experimental passage generation (i.e. cells at the 5th and 19th
passages respectively). On thawing, these cells were injected intraperitoneally
(i.e. passages 6 and 20 respectively) to produce sufficient fresh viable cells (1 x 109
ascites cells from one rat) for experimental use at the 7th and 21st passages.
Economy ofliquidnitrogenbank space was achievedbykeeping cells ofa " primary
stock " which were from the previous passage generation twice removed from that
of the " working stock " (i.e. cells at the 3rd and 17th passages respectively).
Cells of the " working stock " were replenished as they were used experimentally
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by growing up cells in rats from the primary stock. Passage generations 7 and
21 were designated as sublines WBP1(A) and WBP1(V) respectively. Fig. 1
summarizes the derivation ofthis tumour system.
The relative malignanoy of tumour 8ub-lines WBPI(A) and WBP1(V).-
Initially malignancy was assessedbyestimatingLD50butthisprovedimpracticable
as even at the 6th passage generation the LD50 was < 10 cells. Therefore, the
mean death times of rats injected with the same dose (usually 4-5 X 107 viable
cells) ofeither WBP1(A) or WBP1(V) were compared. Stock cells ofthe 5th and
19th passages were grown up to provide inocula for these experiments (Fig. 1).
Passage
Approximate
M.D.T. Days
(Inoculum
ca. 1 x 108 cells)
Benzopyrene pellet s/c
Solid tumour
2 11.12.64
3 13.1.65
4 1.2.65
5 24.2.65
6 11.3.65
7 31.3.65
17 13.8.65
18 25.8.65
19 7.9.65
20 21.9.65
21 2.10.65
39
x
(ascites) X--'-
X
33
25
28
18
20
17
16
15
X-- o-.
i
X
Frozen: PRIMARY STOCK
Intermediate passage
Frozen: WORKING STOCK
Intermediate passage
EXPERIMENTAL CELLS WBP1(A)
Frozen: PRIMARY STOCK
Intermediate passage
Frozen: WORKING STOCK
Intermediate passage
EXPERIMENTAL CELLS WBP1(V)
FIG. 1.-The derivation in rats of tumour WBP1 and its sublines.
Number Date
15.4.64
1 13.11.64
tDERIVATION OF RAT AND MOUSE TUMOUR SUBLINES
In addition, the effect on the mean death times ofchanges in the tumour cell dose,
ofchanges in weight ofthe rats and ofsex have been studied (Table I).
Clearly, subline WBP1(V) is more malignant than subline WBPI(A). The
differences in mean death times were consistent in separate comparisons using
cells grown from different frozen aliquots of the stock. As expected, decreasing
the inoculum of both tumour sublines produced an increase in mean death time.
Differences in mean death time observed with a fixed dose (1 X 107 cells) of the
same tumour in rats ofdifferent weight and sex were much smaller than differences
produced by the two sublines.
TABLE I.-Mean Death Times of Rats Following the Intraperitoneal Inoculation of the Sub-lines
of the Tumour WBP1
Subline WBP1(V)
A~~~
Subline WBP1(A)
Inoculum Rats Initial weight
No. of No. and (g.)
Experiment cells sex mean + s.e.
1 . 4 5X 107 . 20 m 225 9±3-3
, . 19 m
, . 10 m
, . 10 m
Effect of size of inoculum
1X107 . 10 m
IX106
1X105 . ,
1X 104 . ,
1x103 . ,
1 X 102 . J,
1X10 .O ,
257 7±3 4
294 0±4 6
313 3±5 4
Mean death
time (days)
± s.e.
15 7±0 5
15 6±0 3
16 0±0 8
13 2±0 7
16 2±0 2
18 1±1 1
20-5±1- 0
254 9±5 6 21 7±0 3
24- 7±1-9(9*)
26- 0 1 -0(8*)
30-0±2* 1(9*)
6 Effect of weight and sex
1X 107 . 1O m 305-0±2-3
,,.1 ,, 9 331 5±1 8
,, . ,, 262 3±54
,, . ,,9 276 1±6 5
,, . ,, 9 215 2±3 2
,, . ,, 9 214 4±4 6
,, . 10f 204*7±2-8
,, . l,, 192 0±1 8
15 4±0 9
16 6±0 7
16-2±0- 2
155±0-5
17-1±1-1
15 8±1-0
14-9±0-3
15-7±0-7
Rats
No. and
sex
20 m
19 m
10 m
10 m
10 m
,,9
,, 5
,,3
,,9
,,9
,,
10 m
,,9
,,9
,,~
10 f
,,1
Initial weight
(g.)
mean ± s.e.
229 8±3 2
2549±3- 6
290 6±5* 8
307 3±7 2
Mean death
time (days)
± s.e.
28-9±0 6
32*3±1 7
34 4±2 9
30 1±2*2
35 5±2 1
38 5±2 3
42 2+1 6
257-7±5 7 47 5±1-4
45 1±3-2
48 0±2 7(8*)
55. 72 ±5(9*)
333-0±1 7
330-2±1-4
255-44-±2
288- 1±7- 4
205-33-6
208 9±2 1
198 1±1 - 6
192-0±2-8
37-1±3 0
38-3±3- 4
35-5±2 1
31-4±2- 5
32-0±2o8
33 7±3 0
31- 3±17
27 0±3-2
(n*) signifies only n/10 animals died; mean death time was based on these.
The data of experiments 1-4 were combined to provide overall mean death times of 15-3 (± s.e. 0 3) days for
WBP1(V) and 31-1 (± s.e. 0.9) days for WBP1(A).
Tumours in AKR mice
Ascites tumours.-Five ascites tumours derived from solid spontaneous lympho-
mas were examined to see whether the mean death times ofinjected mice decreased
on serial animal passage. In all cases the mean death times were low initially
(< 16 days) and did not decrease significantly on subsequent passageofthetumour.
The derivation oftwo sublines ofdiffering malignancyfrom a solid tumour K12.-
One solid tumour (K12) of 12 lymphomas which did not produce ascites tumours
on serial passage (after dispersion-as described in Methods) was chosen; it
produced a soft enlarged mesenteric lymph node, easily dispersed to a suspension
of viable single cells. A decrease in the mean death time produced by the same
2
3
4
5
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cell dose, occurred during successive passages. Passage generations 6 and 14 were
chosen for comparative studies and a " double stock " system ofcells was prepared
as described for the rat tumour. The cells from passage 6 were designated K12(A)
and those from passage 14 as K12(V) (Fig. 2).
The relative malignancy of tunmour s3ublines K12(A) and K12(V).-The mean
death times of mice injected with the same dose of K.12(A) or K12(V) have been
compared. Stock cells of the 4th and 12th generations were grown to produce
inocula for these estimations. A significant difference in malignancy between
the sublines K12(A) and K12(V) was apparent in all experiments despite the large
Passage
Approximate
M.D.T. Days
(Inoculum
Number ca. 1 x 106 cells)
29
22
11
Solid spontaneous lymphoma. Dispersed
and injected intraperitoneally
4
- Frozen: Reserve
4
X-~ Frozen: PRIMARY STOCK
X-~ Frozen: WORKING STOCK
X
Intermediate passage
A X
EXPERIMENTAL CELLS K12(A)
i
XL Frozen: Reserve
12
X - - Frozen:
X - - Frozen:
X
PRIMARY STOCK
WORKING STOCK
Intermediate passage
EXPERIMENTAL CELLS K12(V)
FIGe. 2.-The derivation in AKR mice of tumour K12 and its sublines.
1
2
3
4
5
6
7
8
9
10
11
12 11
13
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variation of the death times produced by subline K12(A) as compared with
K12(V) (Table II). The reason for the relatively low mean death time produced
by K12(A) in experiment 16 is unknown.
TABLE 11.-MJean Death Times of Mice (AKR) Following the Intraperitoneal
Inoculation of the Sublines of the Tumour K12
Subline K12(V) Subline K12(A)
Mean death Mean death
No. time ± s.e. No. time 4- s.e.
Experiment and sex days and sex days
11 . l0im 10-7±0-4 . lOim 24-1±0-6
16a* . lOf 12 8±0 9 . l0f 17-8±0-2
16b* . l0f 11-4±0-4 lOf 17-3±0-2
17 . 20 f 12-5±1-2 . 20 f 24-6±2-0
19 . 16 f 11-4±1-1 . 16 f 26-8±1-8
10 m 12-1±2-3 . 10m 35 5±5 1
20 . 16 f 11-4±1-0 . 15 f 23-4±3-9
10 m 11-0±0-9 lOim 21-3±3-5
21 . 16 f 11-442-3 . 15 f 26-2±3-5
22 . . 16 f 33-5±2-6
The inoculum was 1 x 106 viable cells and the mice weighed 20-24 g. except in experiment 11
when the range was 25-27 g.
* In experiment 16 a comparison was made between cells from mesenteric lymph nodes from which
any contaminating ascites cells had (16b) and had not (16a) been removed by extensive washing.
The results refuted the possibility that the higher malignancy of K12(V) was due to contamination
with a small number ofhighly malignant ascites cells.
The data of these experiments were combined to provide overall mean death times of 11-6 ± 0.8
days for K12(V) and 25-1 ± 4-7 days for K12(A).
DISCUSSION
The compatibility ofthe tumour systems with the hosts, which might have been
expected since they were derived by a limited number of passages in isogeneic
animals, was indicated by the ability of small numbers of cells (< 10) of all sub-
lines to cause death in a high proportion of hosts. This probable absence of a
strong influence of transplantation antigens, unlike that which occurs with
transplantable tumourlines oflong standing andwith systems derivedfrom culture
in vitro, should be an advantage in future studies on the basis ofmalignancy. In
addition, the fact that the tumours are ascitic or easily dispersed to single cell
suspensions will aid the application of quantitative microbiological techniques.
SUMMARY
Sublines of differing malignancy have been prepared from 2 tumours-a
carcinogen induced rat tumour and a spontaneous tumour in AKR mice-by
tumour progression in isogeneic animals. The rat tumour sublines of high
(WBP1(V)) and low (WBP1(A)) malignancy were ascitic and produced mean
death times of 15-3 days and 31.1 days respectively when 4-5 x 107 cells were
injected intraperitoneally into rats. The mouse tumour sublines of high (K12
(V)) and low (K12(A)) malignancy were easily dispersable tumours of the mesen-
teric lymph nodes and produced mean death times of 11.6 days and 25 1 days
respectively when 1 x 106 cells were injected intraperitoneally into AKR mice.366 H. SMITH, A. E. WILLIAMS, R. S. LOWERY AND J. KEPPIE
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